SMTL ID : 4uhi.1

HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.04 Å

Oligo State

homo-tetramer

Ligands

4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 24 residues within 4Å: Chain A: Y.71, Y.85, F.92, K.96, L.103, L.248, A.251, G.252, T.255, P.316, I.317, M.320, R.322, P.381, F.382, G.383, H.387, R.388, C.389, I.390, G.391, F.394, A.395 Ligands: VFV.2 17 PLIP interactions: 17 interactions with chain A, Hydrophobic interactions: A:L.103, A:L.248, A:A.251, A:T.255, A:P.316, A:I.317, A:F.382, A:F.382, A:I.390, A:F.394, A:A.395 Hydrogen bonds: A:Y.85, A:H.387 Salt bridges: A:K.96, A:R.322, A:H.387 Metal complexes: A:C.389 HEM.4: 23 residues within 4Å: Chain B: Y.85, F.92, K.96, L.103, L.248, A.251, G.252, T.255, P.316, I.317, M.320, R.322, P.381, F.382, G.383, H.387, R.388, C.389, I.390, G.391, F.394, A.395 Ligands: VFV.5 20 PLIP interactions: 20 interactions with chain B, Hydrophobic interactions: B:F.92, B:K.96, B:L.103, B:L.248, B:A.251, B:T.255, B:P.316, B:I.317, B:F.382, B:I.390, B:I.390, B:F.394, B:A.395 Hydrogen bonds: B:Y.85, B:H.387 Water bridges: B:K.96 Salt bridges: B:K.96, B:R.322, B:H.387 Metal complexes: B:C.389 HEM.7: 22 residues within 4Å: Chain C: Y.85, F.92, K.96, L.103, L.248, A.251, T.255, P.316, I.317, M.320, R.322, P.381, F.382, G.383, H.387, R.388, C.389, I.390, G.391, F.394, A.395 Ligands: VFV.8 15 PLIP interactions: 15 interactions with chain C, Hydrophobic interactions: C:K.96, C:L.103, C:L.248, C:A.251, C:P.316, C:F.382, C:I.390, C:I.390, C:F.394, C:A.395 Hydrogen bonds: C:H.387 Salt bridges: C:K.96, C:R.322, C:H.387 Metal complexes: C:C.389 HEM.10: 22 residues within 4Å: Chain D: Y.71, Y.85, F.92, K.96, L.248, A.251, G.252, T.255, P.316, I.317, M.320, R.322, P.381, F.382, G.383, H.387, R.388, C.389, I.390, G.391, A.395 Ligands: VFV.11 14 PLIP interactions: 14 interactions with chain D, Hydrophobic interactions: D:L.248, D:P.316, D:F.382, D:F.382, D:I.390, D:A.395 Hydrogen bonds: D:Y.71, D:Y.85, D:H.387 Salt bridges: D:K.96, D:R.322, D:H.387, D:H.387 Metal complexes: D:C.389

8 x VFV: N-[(1R)-1-(3,4'-difluorobiphenyl-4-yl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide(Non-covalent)

VFV.2: 20 residues within 4Å: Chain A: Y.71, L.74, T.75, F.79, A.84, F.92, L.99, F.174, S.175, W.179, M.244, G.247, L.248, L.250, A.251, T.255, I.317, M.427 Ligands: HEM.1, VFV.3 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:Y.71, A:L.74, A:T.75, A:F.79, A:F.79, A:A.84, A:F.92, A:F.92, A:F.174, A:W.179, A:A.251 pi-Stacking: A:H.176, A:W.179 VFV.3: 16 residues within 4Å: Chain A: F.17, M.40, V.41, F.45, Y.47, Y.71, H.176, W.179, P.316, I.319, M.321, C.342 Chain B: L.185, P.186, L.187 Ligands: VFV.2 6 PLIP interactions: 1 interactions with chain B, 5 interactions with chain A Hydrophobic interactions: B:L.187, A:V.41, A:W.179, A:I.319 Hydrogen bonds: A:Y.47 pi-Stacking: A:F.45 VFV.5: 20 residues within 4Å: Chain B: Y.71, L.74, T.75, F.79, A.84, F.92, L.99, F.174, S.175, H.176, W.179, M.244, G.247, L.248, L.250, A.251, T.255, I.317 Ligands: HEM.4, VFV.6 12 PLIP interactions: 12 interactions with chain B Hydrophobic interactions: B:L.74, B:T.75, B:F.79, B:F.79, B:A.84, B:F.92, B:F.92, B:F.174, B:W.179, B:A.251 pi-Stacking: B:Y.71, B:H.176 VFV.6: 17 residues within 4Å: Chain A: L.185, P.186, L.187 Chain B: F.17, M.40, V.41, F.45, Y.47, Y.71, H.176, W.179, L.180, I.319, M.321, C.342, M.427 Ligands: VFV.5 13 PLIP interactions: 12 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:V.41, B:V.41, B:Y.71, B:W.179, B:W.179, B:L.180, B:I.319, B:M.427, A:P.186 Hydrogen bonds: B:Y.47 pi-Stacking: B:F.17, B:F.45, B:H.176 VFV.8: 20 residues within 4Å: Chain C: Y.71, L.74, T.75, F.79, A.84, F.92, L.99, F.174, S.175, W.179, M.244, G.247, L.248, L.250, A.251, T.255, I.317, M.427 Ligands: HEM.7, VFV.9 14 PLIP interactions: 14 interactions with chain C Hydrophobic interactions: C:Y.71, C:L.74, C:T.75, C:F.79, C:A.84, C:F.92, C:F.92, C:L.99, C:F.174, C:F.174, C:W.179, C:W.179, C:A.251 pi-Stacking: C:H.176 VFV.9: 15 residues within 4Å: Chain C: F.17, M.40, V.41, F.45, Y.47, Y.71, H.176, W.179, I.319, M.321, I.428 Chain D: L.185, P.186, L.187 Ligands: VFV.8 5 PLIP interactions: 5 interactions with chain C Hydrophobic interactions: C:V.41, C:Y.71, C:I.319, C:I.428 Hydrogen bonds: C:Y.71 VFV.11: 21 residues within 4Å: Chain D: Y.71, L.74, T.75, F.79, A.84, F.92, L.99, F.174, S.175, H.176, W.179, M.244, G.247, L.248, L.250, A.251, T.255, I.317, M.427 Ligands: HEM.10, VFV.12 13 PLIP interactions: 13 interactions with chain D Hydrophobic interactions: D:Y.71, D:L.74, D:T.75, D:F.79, D:F.79, D:F.79, D:A.84, D:F.92, D:F.174, D:W.179, D:W.179, D:A.251 pi-Stacking: D:H.176 VFV.12: 17 residues within 4Å: Chain C: L.185, P.186, L.187 Chain D: F.17, F.38, M.40, V.41, F.45, Y.47, H.176, W.179, L.180, I.319, M.321, M.427, I.428 Ligands: VFV.11 9 PLIP interactions: 8 interactions with chain D, 1 interactions with chain C Hydrophobic interactions: D:V.41, D:V.41, D:L.180, D:I.319, D:M.427, D:I.428, C:P.186 pi-Stacking: D:F.45, D:H.176

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hargrove, T.Y. et al., Human Sterol 14Alpha-Demethylase (Cyp51) as a Target for Anticancer Chemotherapy: Towards Structure-Aided Drug Design. J.Lipid Res. (2016)

Release Date

2016-06-08

Peptides

STEROL 14-ALPHA DEMETHYLASE: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

STEROL 14-ALPHA DEMETHYLASE